Improving In Vitro Digestibility and Reducing Immunogenic Peptide Exposure in Soybean Meal through Exogenous Protease Supplementation.
Soybean meal has always been a staple in animal feed, but digestibility and allergenic peptides limit its full potential. New research from Zafra and colleagues shows exogenous proteases can change the game—boosting protein breakdown and slashing the number of immune-triggering peptide fragments.
J Agric Food Chem
by Zafra L, Jiménez-Holgado C, Vasanthakumari BL et al.
“Improving In Vitro Digestibility and Reducing Immunogenic Peptide Exposure in Soybean Meal through Exogenous Protease Supplementation. Zafra L(1)(2), Jiménez-Holgado C(1), Vasanthakumari BL(3), Miralles B(1), Martinez-Sanz M(1), Recio I(1). Author information: (1)Instituteof Food Science Research, CIAL (CSIC-UAM, CEI UAM+CSIC), C. Nicolás Cabrera, 9, 28049 Madrid, Spain. (2)Escuela de Doctorado, Universidad Autónoma de Madrid (UAM), C. Francisco Tomas y Valiente, 7, 28049 Madrid, Spain. (3)Kemin Industries, 1900 Scott Ave, Des Moines, lowa 50317, United States. Exogenous proteases can enhance protein digestion in feed. However, their precise impact on peptide release and allergenecity remains poorly understood. This study evaluated the effects of a protease blend (Protease I) and a single protease (Protease II) on soybean meal in vitro digestibility and peptide release, using the standardized INFOGEST model. Compared to the Control, Proteases I and II increased protein digestibility from 83-89% to 90-96% and 91-92%, respectively, while enhancing peptide release from typically enzyme-resistant regions. Peptide profiling showed broader sequence coverage of key soybean proteins and revealed distinct substrate specificities. Cleavage site analysis indicated that exogenous enzymes altered the proteolytic pattern. Importantly, epitope sequence comparison revealed that enzymatic hydrolysis reduced the presence of certain allergenic epitopes. These findings suggest that protease supplementation enhances digestibility and may reduce allergenic potential, offering a promising strategy to improve the nutritional quality and safety of plant-based feed proteins.”
Here’s what happened: The team compared two different protease approaches—one blend (Protease I), one single enzyme (Protease II)—against a control using the standardized INFOGEST in vitro digestion model. Both protease treatments pushed digestibility up fast. Protease I took protein digestibility from 83-89% all the way to 90-96%. Protease II clocked in at 91-92%. That’s not just a little better; it’s a meaningful bump for anyone optimizing plant protein use.
But the story gets more interesting with peptide profiling:
Broader peptide sequence coverage means more of the soybean protein gets broken down.
The enzymes showed unique substrate preferences, producing different peptide patterns.
Cleavage site analysis confirmed the proteases changed where and how proteins were chopped up.
The real kicker: Allergenic epitope mapping. Enzymatic hydrolysis with these proteases reduced the presence of certain known allergenic peptide sequences. For anyone concerned about feed safety or hypoallergenic formulations, this is a solid step forward.
Key takeaway: Exogenous proteases don’t just improve overall protein digestibility—they also change the peptide landscape in ways that could make plant-based feeds safer and more useful.
For more updates and trends in the space, check out the peptide research index. This research is a win for protein scientists and feed formulators looking to push plant proteins further.
Related Reading
The STRIDE Trial and Semaglutide: Implications for Clinical Vascular Practice.
News · J Med ChemStructure-Based Adaptation of a SARS-CoV-2 Neutralizing Peptide to New Virus Variants.
News · J Nucl MedCombining an α(v)β(6)-Targeted (177)Lu-Based Peptide Receptor Radionuclide Therapy with Olaparib to Boost Therapeutic Efficacy in Pancreatic Cancer.
For Research Use Only
All content published on Pushing Peptides is intended for educational and informational purposes only. The information provided is not intended as medical advice, diagnosis, or treatment. Peptides discussed in this article are research compounds and are not approved for human therapeutic use by the FDA or any other regulatory agency. All studies referenced involve animal models or in vitro research unless otherwise stated. Consult a qualified healthcare professional before making any decisions related to your health. Pushing Peptides does not sell peptides — we are a vendor directory and educational resource.